Skip to main content
Watch Insiders
KPTIHealthcare

Karyopharm Therapeutics Inc (KPTI) Insider Trading

In the last 90 days, 1 Karyopharm Therapeutics Inc (KPTI) insider reported no open-market purchases and 3 sales totaling $2,135. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 16, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 16, 2026Kristin AbateChief Accounting OfficerSale4,788$0.34$1,647
Oct 1, 2026Kristin AbateChief Accounting OfficerSale378$1.19$449.82
Sep 1, 2026Kristin AbateChief Accounting OfficerSale19$2.02$38.38
Jul 28, 2026Stuart PoultonEVP, Chief Development OfficerSale189$7.10$1,342
May 14, 2026Stuart PoultonEVP, Chief Development OfficerSale403$9.50$3,829
May 14, 2026Reshma RangwalaEVP & Chief Medical OfficerSale408$9.50$3,876
May 14, 2026Sohanya Roshan ChengEVP & Chief Commercial OfficerSale324$9.50$3,078
May 14, 2026Kristin AbateChief Accounting OfficerSale53$9.50$503.50
May 14, 2026Richard A. PaulsonPresident and CEOSale2,203$9.50$20,929
May 14, 2026Michael ManoEVP, CLO&SecretarySale266$9.50$2,527
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

KPTI insider trading FAQ

Are KPTI insiders buying or selling?
Over the last 90 days, KPTI insiders were net sellers, reporting $0.00 of open-market purchases and $2,135 of sales.
When was the last KPTI insider purchase?
No open-market insider purchase of Karyopharm Therapeutics Inc stock was reported in the last 90 days.
Where does KPTI insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Karyopharm Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.